Trial NCT05496192

View at ClinicalTrials.gov 
Org. Study IDs: CA209-6L6
Secondary IDs: 2022-000294-67 U1111-1273-4725

Last trial update was posted on 2023-04-14

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Melanoma

Other Conditions

Urothelial Carcinoma

Stopping Reasons

Replaced it with another clinical trial

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID